Carcinotech to partner with Swedish biotech firm Cellink on cancer research

portrait of a

Life sciences business Carcinotech has agreed a partnership with Swedish firm Cellink to research treatments for brain tumours and breast cancer.

Carcinotech, based at Roslin Innovation Centre near Edinburgh, uses bioinks to print microscopic 3D models of cancer cells which can be used to test potential treatments.

Read the full article here

Related Posts

About Us

Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells.

Let’s Socialize

Popular Post